Artificial Intelligence company Life Whisperer has demonstrated through a U.S. patient study that its AI can detect Down Syndrome in human embryos. In partnership with Ovation Fertility, the collaborative study validates the first non-invasive technology to identify specific chromosomal abnormalities using morphological assessment through artificial intelligence.
Life Whisperer is underpinned by Presagen’s image-based medical diagnostics platform, an advanced AI tool purpose built to rapidly create and deploy clinical tools for analyzing medical images using deep learning and computer vision. Presagen was also built by Life Whisperer’s co-founding and multi-disciplinary team, which has over 20 years of AI experience in developing and deploying AI products for real world problems.
Click here to view the press release or visit LifeWhisperer.co.